Moclobemide: a paradigm of research in clinical psychopharmacology

@article{Angst1996MoclobemideAP,
  title={Moclobemide: a paradigm of research in clinical psychopharmacology},
  author={Jules Angst and R. Amrein and Max Stabl},
  journal={International Clinical Psychopharmacology},
  year={1996},
  volume={11},
  pages={3-7}
}
The pre-clinical development of moclobemide is an example of broad research combined with serendipity. Moclobemide was first hypothesized as being an antilipaemic or antibiotic, but the screenings were negative. The search for its antidepressant qualities, based on anticholinergic tests, also proved negative and moclobemide was then suspected of being an antipsychotic before its specific and reversible monoamine oxidase (MAO)-A inhibition qualities were detected. After the establishment of its… Expand
5 Citations
Monoamine oxidase inhibitors (including the newer reversible compounds)
In the mid-1950s the chance finding of iproniazid’s mood-elevating properties [1] led to the discovery that inhibition of monoamine oxidase (MAO) results in changes in cerebral function. MonoamineExpand
New developments in obsessive‐compulsive disorder research: implications for clinical management
TLDR
Some of the recent developments which have enhanced the understanding of OCD are reviewed and their potential impact on clinical management is considered. Expand
New Biological Models of OCD: Implications of Subtypes
Neurobiological studies continue to generate new clues to the pathophysiology of obsessive-compulsive disorder (OCD). Currently, the weight of evidence implicates serotonin (5-hydroxytryptamine,Expand
Antidepressants: Using Pharmacology to Individualize Therapy
TLDR
The pharmacologic profile of antidepressants currently marketed in the United States is discussed, identifying similarities and differences that have clinical relevance in the management of depression. Expand
Negative symptoms: diagnosis, treatment and prognosis
TLDR
The importance of developing effective treatments for primary negative symptoms is underscored by the relationship of these symptoms to poor social, occupational, and global outcome. Expand